Is Hikma (LSE:HIK) Reshaping Its Growth Story With A Semaglutide Launch And R&D Spotlight This Week?

Is Hikma (LSE:HIK) Reshaping Its Growth Story With A Semaglutide Launch And R&D Spotlight This Week? →

Highlights Hikma launched Glucentra, a generic semaglutide, for patients in Saudi Arabia. The group hosted an R&D Investor Spotlight Series to showcase its pipeline. An epinephrine nasal spray moved forward through multi-market regulatory f…